Zusammenfassung
Das Spektrum der Pharmakotherapie in der psychiatrischen Notfalltherapie wird ausführlich beschrieben. Das delirante Syndrom nimmt breiteren Raum ein. Die Intoxikationen sind den spezifischen Kapiteln zugeteilt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Al-Qadheeb NS, Balk EM, Fraser GL et al (2014) Randomized ICU trials do not demonstrate an association between interventions that reduce delirium duration and short-term mortality: a systematic review and meta-analysis. Crit Care Med 42: 1442–1454
Al-Qadheeb NS, Skrobik Y, Schumaker G et al (2016) Preventing ICU subsyndromal delirium conversion to delirium with low-dose IV haloperidol: a double-blind, placebo-controlled pilot study. Crit Care Med 44(3): 583–591
Barr J, Fraser GL, Puntillo K et al (2013) Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 41(1): 263–306
Barry H, Byrne S, Barrett E et al (2015) Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment. B J Psych Bull 39: 19–23
Bosanac P, Hollander Y, Castle D (2013) The comparative efficacy of intramuscular antipsychotics for the management of acute agitation. Australas Psychiatry 21(6): 554–562
Brydges D, Tibrewal P, Waite S et al (2015) Use of dexmedetomidine in treatment-refractory post-electroconvulsive therapy agitation. Aust N Z J Psychiatry 50(4): 386–387
Citrome L, Volavka J (2014) The psychopharmacology of violence: making sensible decisions. CNS Spectr 26: 1–8
Devlin JW, Michaud CJ, Bullard HM et al (2016) Quetiapine for intensive care unit delirium: the evidence remains weak. Pharmacotherapy 36: e12–e14
Drach LM (2014) Symptomatische Psychopharmakotherapie des Delirs im Alter. Psychopharmakotherapie 21(2): 56–63
Fleminger S, Greenwood RJ, Oliver DL (2006) Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database Syst Rev (4): CD003299
Friedman JI, Soleimani L, McGonigle DP et al (2014) Pharmacological treatments of non-substance-withdrawal delirium: a systematic review of prospective trials. Am J Psychiatry 171(2): 151–159
Gault TI, Gray SM, Vilke GM, Wilson MP (2012) Are oral medications effective in the management of acute agitation? J Emerg Med 43(5): 854–859
Gerresheim G, Schwemmer U (2013) Dexmedetomidin. Anaesthesist 62(8): 661–674
Gillies D, Sampson S, Beck A et al (2013) Benzodiazepines for psychosis-induced aggression or agitation. Cochrane Database Syst Rev 9: CD003079
Hatta K, Kishi Y, Wada K et al (2014a) Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry 71(4): 397–403
Hatta K, Kishi Y, Wada K et al (2014b) Antipsychotics for delirium in the general hospital setting in consecutive 2453 inpatients: a prospective observational study. Int J Geriatr Psychiatry 29(3):253–62.
Huf G, Alexander J, Allen MH, Raveendran NS (2009) Haloperidol plus promethazine for psychosis-induced aggression. Cochrane Database Syst Rev (3): CD005146
Hüfner H, Sperner-Unterweger B (2014) Delir in der Neurologie. Nervenarzt 85(4): 427–436
Jayakody K, Gibson RC, Kumar A, Gunadasa S (2012) Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses. Cochrane Database Syst Rev 18(4): CD000525
Kroll KE, Kroll DS, Pope JV et al (2012) Catatonia in the emergency department. J Emerg Med 43(5): 843–846
Lang FU, Lang S, Becker T et al (2015) Neuroleptic malignant syndrome or catatonia? Trying to solve the catatonic dilemma. Psychopharmacology (Berl) 232: 1–5
Lin CC, Huang TL (2013) Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis. Compr Psychiatry 54(8): 1210–1214
Luchini F, Lattanzi L, Bartolommei N et al (2013) Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports. J Nerv Ment Dis 201(1): 36–42
MacDonald K, Wilson M, Minassian A et al (2012) A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation. J Clin Psychopharmacol 32: 317–322
Michaud CJ, Bullard HM, Harris SA et al (2015) Impact of quetiapine treatment on duration of hypoactive delirium in critically ill adults: a retrospective analysis. Pharmacotherapy 35: 731–739
Nagel M, Freisberg S, Junghanns K et al (2015) Das maligne neuroleptische Syndrom (MNS) – Eine systematische Übersicht. Fortschr Neurol Psychiatr 83: 373–380
Narayanaswamy JC, Tibrewal P, Zutshi A et al (2012) Clinical predictors of response to treatment in catatonia. Gen Hosp Psychiatry 34(3): 312–316
Okumura Y, Hatta K, Wada K et al (2016) Expert opinions on the first-line pharmacological treatment for delirium in Japan: a conjoint analysis. Int Psychogeriatr 28(6): 1041–1050
Pollak TA, McCormack R, Peakman M et al (2013) Prevalence of anti-N-methyl-d-aspartate (NMDA) antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis. Psychol Med 13: 1–13
Powney MJ, Adams CE, Jones H (2012) Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database Syst Rev. 11: CD009377
Prüß H (2013) Neuroimmunologie: Neues zur limbischen Enzephalitis. Akt Neurol 40: 127–136
Rolland B, Debien C, Vaiva G (2014) Treatment of agitation in the emergency department: benzodiazepines could be safer than antipsychotics in some cases of insufficient medical data. J Emerg Med 46(6): 830–831
Rothberg MB, Herzig SJ, Pekow PS et al (2013) Association between sedating medications and delirium in older inpatients. Am Geriatr Soc. 61(6): 923–930
Roy A, Hodgkinson CA, Deluca V et al (2012) Two HPA axis genes, CRHBP and FKBP5, interact with childhood trauma to increase the risk for suicidal behavior. J Psychiatr Res 46(1): 72–79
Rundshagen I (2014) Postoperative kognitive Dysfunktion. Dt Ärztebl 111(8): 119–125
Serafim RB, Bozza FA, Soares M et al (2015) Pharmacologic prevention and treatment of delirium in intensive care patients: a systematic review. J Crit Care 30: 799–807
Silvestre JS, Prous JR (2007) Comparative evaluation of hERG potassium channel blockade by antipsychotics. Methods Find Exp Clin Pharmacol 29(7): 457–465
Steiner J, Walter M, Glanz W et al (2013) Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis JAMA Psychiatry 70(3): 271–278
Utzerath G, Reske D, Gouzoulis-Mayfrank E (2015) Parenteral applizierte Antipsychotika bei Agitation und Aggression. Fortschr Neurol Psychiatr 83: 665–675
Wang HR, Woo YS, Bahk WM (2013) Atypical antipsychotics in the treatment of delirium. Psychiatry Clin Neurosci 67(5): 323–331
Wilson MP, Pepper D, Currier GW et al (2012) The psychopharmacology of agitation: consensus statement of the American Association for Emergency Psychiatry project Beta Psychopharmacology Workgroup. West J Emerg Med 13(1): 26–34
Wilson MP, Minassian A, Bahramzi M et al (2014) Despite expert recommendations, second-generation antipsychotics are not often prescribed in the emergency department. J Emerg Med 46(6): 808–813
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Müller, M., Benkert, O. (2017). Pharmakotherapie psychiatrischer Notfallsituationen. In: Benkert, O., Hippius, H. (eds) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-50333-1_12
Download citation
DOI: https://doi.org/10.1007/978-3-662-50333-1_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-50332-4
Online ISBN: 978-3-662-50333-1
eBook Packages: Medicine (German Language)